The Scientist

» media relations and genetics & genomics

Most Recent

image: Venter's New Venture

Venter's New Venture

By | March 5, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

0 Comments

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

8 Comments

image: More Mutations in Girls with Autism

More Mutations in Girls with Autism

By | March 4, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

1 Comment

image: Dad’s Contribution

Dad’s Contribution

By | February 28, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

0 Comments

image: Week in Review: February 24–28

Week in Review: February 24–28

By | February 28, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

0 Comments

image: Plants Without Plastid Genomes

Plants Without Plastid Genomes

By | February 28, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

1 Comment

image: Genomenclature?

Genomenclature?

By | February 24, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

2 Comments

image: OCD-Linked Canine Genes

OCD-Linked Canine Genes

By | February 19, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

3 Comments

image: Not Swine Flu

Not Swine Flu

By | February 18, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

0 Comments

image: Genetic Atlas

Genetic Atlas

By | February 17, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech